Pharmaceutical Care for Adrenal Crisis Induced by Sintilimab Immunotherapy
-
Senling Ye
,
Jian Lou
,
Xiayan Zhang
,
Songmei Luo
,
Yanru Xie
,
Yanyan Zhu
Abstract
No abstract
1. Iglesias P, Sánchez JC, Díez JJ. Isolated ACTH deficiency induced by cancer immunotherapy: a systematic review. Pituitary. 2021;24(4):630-43.
2. Kanie K, Iguchi G, Bando H, Urai S, Shichi H, Fujita Y, et al. Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome. Cancer Immunology, Immunotherapy: CII. 2021;70(12):3669-77.
3. Iwama S, Kobayashi T, Arima H. Clinical Characteristics, Management, and Potential Biomarkers of Endocrine Dysfunction Induced by Immune Checkpoint Inhibitors. Endocrinology and Metabolism (Seoul, Korea). 2021;36(2):312-21.
4. Kobayashi T, Iwama S, Yasuda Y, et al. Anti-pituitary antibodies and susceptible human leukocyte antigen alleles as predictive biomarkers for pituitary dysfunction induced by immune checkpoint inhibitors. J Immunother Cancer. 2021;9(5):e002493.
5. Crowder SL, Playdon MC, Gudenkauf LM, Ose J, Gigic B, Greathouse L, et al. A Molecular Approach to Understanding the Role of Diet in Cancer-Related Fatigue: Challenges and Future Opportunities. Nutrients. 2022;14(7):1496.
6. Wang F, Shi X, Yu X, Yang Y. Immune checkpoint inhibitor-induced isolated adrenocorticotropic hormone deficiency: a systematic review. Front Endocrinol (Lausanne). 2024 Jan 22;15:1326684.
7. Skowrońska-Jóźwiak E, Orzechowski S, Piętak W, Lewiński A. Rare clinical problem - isolated ACTH deficiency associated with chronic alcohol abuse. Endokrynol Pol. 2022;73(4):778-83.
2. Kanie K, Iguchi G, Bando H, Urai S, Shichi H, Fujita Y, et al. Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome. Cancer Immunology, Immunotherapy: CII. 2021;70(12):3669-77.
3. Iwama S, Kobayashi T, Arima H. Clinical Characteristics, Management, and Potential Biomarkers of Endocrine Dysfunction Induced by Immune Checkpoint Inhibitors. Endocrinology and Metabolism (Seoul, Korea). 2021;36(2):312-21.
4. Kobayashi T, Iwama S, Yasuda Y, et al. Anti-pituitary antibodies and susceptible human leukocyte antigen alleles as predictive biomarkers for pituitary dysfunction induced by immune checkpoint inhibitors. J Immunother Cancer. 2021;9(5):e002493.
5. Crowder SL, Playdon MC, Gudenkauf LM, Ose J, Gigic B, Greathouse L, et al. A Molecular Approach to Understanding the Role of Diet in Cancer-Related Fatigue: Challenges and Future Opportunities. Nutrients. 2022;14(7):1496.
6. Wang F, Shi X, Yu X, Yang Y. Immune checkpoint inhibitor-induced isolated adrenocorticotropic hormone deficiency: a systematic review. Front Endocrinol (Lausanne). 2024 Jan 22;15:1326684.
7. Skowrońska-Jóźwiak E, Orzechowski S, Piętak W, Lewiński A. Rare clinical problem - isolated ACTH deficiency associated with chronic alcohol abuse. Endokrynol Pol. 2022;73(4):778-83.
| Files | ||
| Issue | Articles in Press | |
| Section | Case Report(s) | |
| Keywords | ||
| No keyword | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Ye S, Lou J, Zhang X, Luo S, Xie Y, Zhu Y. Pharmaceutical Care for Adrenal Crisis Induced by Sintilimab Immunotherapy. Iran J Allergy Asthma Immunol. 2026;:1-6.
